Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Profound Medical Affirms FY2024 Sales Guidance to $11.00M-12.00M VS Est. $11.23M

Author: Benzinga Newsdesk | November 07, 2024 05:59pm

Profound Medical (NASDAQ:PROF) affirms FY2024 sales outlook from $11.00 million-12.00 million to $11.00 million-12.00 million.

Posted In: PROF